|
MechanismS1: Chymotrypsin stimulants [+2] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Propanc Pty Ltd.
0 Patents (Medical) associated with Propanc Pty Ltd.
100 Deals associated with Propanc Pty Ltd.
100 Translational Medicine associated with Propanc Pty Ltd.